Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 89

Results For "IFF"

1272 News Found

Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India


USFDA approves Novartis Pluvicto to treat prostrate cancer
Drug Approval | March 24, 2022

USFDA approves Novartis Pluvicto to treat prostrate cancer

USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions


Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh
News | March 24, 2022

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh

Kiran will be joining RSE's current Fellowship of around 1,700 Fellows who are recognized as being some of the greatest thinkers, researchers and practitioners working in or with Scotland


Waters introduces  automated solutions for mass and purity analysis of biomolecules
Biotech | March 23, 2022

Waters introduces automated solutions for mass and purity analysis of biomolecules

New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity than conventional steel columns


GOQii India Fit Report 2022 indicates stress levels high amongst Indians
Healthcare | March 23, 2022

GOQii India Fit Report 2022 indicates stress levels high amongst Indians

The survey indicates that 30% of people are still feeling depressed or hopeless on a few days as against GOQii’s last year survey on mental Health where 43% of Indians were depressed


Huma acquires AstraZeneca health platform AMAZE
Digitisation | March 23, 2022

Huma acquires AstraZeneca health platform AMAZE

As part of this partnership, Huma and AstraZeneca will launch Software as a Medical Device (SaMD) companion apps targeted at several therapeutic areas and will partner to help accelerate the adoption of decentralized clinical trials


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


NIBIOHN identifies tissue-specific exosome marker candidates from blood
Biotech | March 22, 2022

NIBIOHN identifies tissue-specific exosome marker candidates from blood

Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease


Trivitron Healthcare elevates Chandra Ganjoo to Group CEO
People | March 22, 2022

Trivitron Healthcare elevates Chandra Ganjoo to Group CEO

She joined Trivitron Healthcare in 1999 and has held several positions in the organisation